Showing results (1521-1530 of 2,557) with videos related to
Sort By:
Pageof 256
Clinical Colorectal Cancer|August 19, 2015
Impact of Weight Changes After the Diagnosis of Stage III Colon Cancer on Survival OutcomesJoanna Vergidis, Gillian Gresham, Howard J Lim, et al.The Journal of Clinical Endocrinology and Metabolism|March 18, 2022
Association Between SGLT2 Inhibitors vs DPP4 Inhibitors and Renal Outcomes Among Patients With Type 2 DiabetesPhilip C M Au, Kathryn C B Tan, Bernard M Y Cheung, et al.Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|April 5, 2023
Preoperative considerations and benefits of neoadjuvant chemotherapy: insights from a 12-year review of the Hong Kong Breast Cancer RegistryY H Y Chan, C C H Kwok, D M S Tse, et al.Clinical Breast Cancer|January 12, 2019
Impact of Baseline Cardiovascular Comorbidity on Outcomes in Women With Breast Cancer: A Real-world, Population-based StudyOmar Abdel-Rahman, Yuan Xu, Shiying Kong, et al.Gynecologic Oncology|November 8, 2005
Expression of maspin in gestational trophoblastic diseaseH W Raymond Li, See Wai Leung, Annie N Y Cheung, et al.Scientific Reports|August 19, 2017
HIV-1 Nef-induced cardiotoxicity through dysregulation of autophagyManish K Gupta, Rafal Kaminski, Brian Mullen, et al.Frontiers in Neurology|January 7, 2021
Differences in Proprioception Between Young and Middle-Aged Adults With and Without Chronic Low Back PainSabina M Pinto, Jason P Y Cheung, Dino Samartzis, et al.Antibodies (Basel, Switzerland)|September 24, 2019
Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B HemagglutininWalter Ramage, Tiziano Gaiotto, Christina Ball, et al.American Journal of Clinical Oncology|September 14, 2018
Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non-Small Cell Lung CancerAmanda J W Gibson, Haocheng Li, Adrijana D'Silva, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2025
A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete RemissionBrian H Kushner, Shakeel Modak, Audrey Mauguen, et al.Pageof 256